Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 236


Putaminal dopamine depletion in de novo Parkinson's disease predicts future development of wearing-off.

Chung SJ, Lee Y, Oh JS, Kim JS, Lee PH, Sohn YH.

Parkinsonism Relat Disord. 2018 May 10. pii: S1353-8020(18)30237-2. doi: 10.1016/j.parkreldis.2018.05.008. [Epub ahead of print]


The cholinergic contribution to the resting-state functional network in non-demented Parkinson's disease.

Lee Y, Ham JH, Cha J, Park YH, Lee JJ, Sunwoo MK, Hong JY, Sohn YH, Lee JM, Lee PH.

Sci Rep. 2018 May 16;8(1):7683. doi: 10.1038/s41598-018-26075-3.


The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage.

Yoo HS, Chung SJ, Kim SJ, Oh JS, Kim JS, Ye BS, Sohn YH, Lee PH.

Eur J Nucl Med Mol Imaging. 2018 May 4. doi: 10.1007/s00259-018-4019-y. [Epub ahead of print]


Parkinson's disease-related non-motor features as risk factors for post-operative delirium in spinal surgery.

Kim KH, Kang SY, Shin DA, Yi S, Ha Y, Kim KN, Sohn YH, Lee PH.

PLoS One. 2018 Apr 9;13(4):e0195749. doi: 10.1371/journal.pone.0195749. eCollection 2018.


Gender-specific effect of uric acid on resting-state functional networks in de novo Parkinson's disease.

Lee Y, Park YH, Lee JJ, Sohn YH, Lee JM, Lee PH.

Parkinsonism Relat Disord. 2018 Mar 26. pii: S1353-8020(18)30138-X. doi: 10.1016/j.parkreldis.2018.03.023. [Epub ahead of print]


Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.

Chung SJ, Yoo HS, Oh JS, Kim JS, Ye BS, Sohn YH, Lee PH.

Parkinsonism Relat Disord. 2018 Mar 2. pii: S1353-8020(18)30114-7. doi: 10.1016/j.parkreldis.2018.02.048. [Epub ahead of print]


INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.

Misra VP, Colosimo C, Charles D, Chung TM, Maisonobe P, Om S; INTEREST IN CD2 study group.

J Neurol. 2018 Feb;265(2):402-409. doi: 10.1007/s00415-017-8698-2. Epub 2017 Dec 21.


Subjective Cognitive Complaints and Objective Cognitive Impairment in Parkinson's Disease.

Hong JY, Lee Y, Sunwoo MK, Sohn YH, Lee PH.

J Clin Neurol. 2018 Jan;14(1):16-21. doi: 10.3988/jcn.2018.14.1.16. Epub 2017 Oct 31.


Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.

Yoo HS, Chung SJ, Chung SJ, Moon H, Oh JS, Kim JS, Hong JY, Ye BS, Sohn YH, Lee PH.

Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):423-431. doi: 10.1007/s00259-017-3844-8. Epub 2017 Oct 26.


Does smoking impact dopamine neuronal loss in de novo Parkinson disease?

Lee Y, Oh JS, Chung SJ, Chung SJ, Kim SJ, Nam CM, Lee PH, Kim JS, Sohn YH.

Ann Neurol. 2017 Nov;82(5):850-854. doi: 10.1002/ana.25082. Epub 2017 Oct 31.


Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.

Ye BS, Jeon S, Yoon S, Kang SW, Baik K, Lee Y, Chung SJ, Oh JS, Moon H, Kim JS, Lee PH, Sohn YH.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):197-204. doi: 10.1136/jnnp-2017-316075. Epub 2017 Sep 26.


Sleepiness and Depression in Parkinson's Disease Patients Treated with Ropinirole and Levodopa.

Kang SY, Ryu HS, Sunwoo MK, Kim SJ, Baik JS, Park MY, Park HE, Kim JS, Kwon KY, Koh SB, Kim YE, Lee MK, Kim JM, Chung SJ, Sohn YH.

J Mov Disord. 2017 Sep;10(3):123-129. doi: 10.14802/jmd.17048. Epub 2017 Sep 22.


Dementia-Predicting Cognitive Risk Score and Its Correlation with Cortical Thickness in Parkinson Disease.

Ye BS, Jeon S, Ham JH, Lee JJ, Lee JM, Lee HS, Lee PH, Sohn YH.

Dement Geriatr Cogn Disord. 2017;44(3-4):203-212. doi: 10.1159/000479057. Epub 2017 Sep 21.


Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.

Chung SJ, Yoo HS, Moon H, Oh JS, Kim JS, Park YH, Hong JY, Ye BS, Sohn YH, Lee PH.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):169-174. doi: 10.1136/jnnp-2017-315873. Epub 2017 Sep 14.


Microstructural white matter alterations in patients with drug induced parkinsonism.

Lee Y, Ho Choi Y, Lee JJ, Lee HS, Sohn YH, Lee JM, Lee PH.

Hum Brain Mapp. 2017 Dec;38(12):6043-6052. doi: 10.1002/hbm.23809. Epub 2017 Sep 12.


Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson's disease.

Chung SJ, Lee Y, Lee JJ, Lee PH, Sohn YH.

Eur J Neurol. 2017 Oct;24(10):1314-1319. doi: 10.1111/ene.13388. Epub 2017 Aug 7.


Erratum to: The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group.

Kwon DY, Koh SB, Lee JH, Park HK, Kim HJ, Shin HW, Youn J, Park KW, Choi SA, Kim SJ, Choi SM, Park JY, Jeon BS, Kim JY, Chung SJ, Lee CS, Park JH, Ahn TB, Kim WC, Kim HS, Cheon SM, Kim HT, Lee JY, Kim JS, Kim EJ, Kim JM, Lee KS, Kim JS, Kim MJ, Baik JS, Park KJ, Kim HJ, Park MY, Kang JH, Song SK, Kim YD, Yun JY, Lee HW, Oh HG, Cho J, Song IU, Sohn YH, Lee PH, Kim JW.

J Clin Neurol. 2017 Jul;13(3):315. doi: 10.3988/jcn.2017.13.3.315.


Subcortical shape analysis of progressive mild cognitive impairment in Parkinson's disease.

Chung SJ, Shin JH, Cho KH, Lee Y, Sohn YH, Seong JK, Lee PH.

Mov Disord. 2017 Oct;32(10):1447-1456. doi: 10.1002/mds.27106. Epub 2017 Jul 24.


Periodically Patterned Au-TiO2 Heterostructures for Photoelectrochemical Sensor.

Guo L, Li Z, Marcus K, Navarro S, Liang K, Zhou L, Mani PD, Florczyk SJ, Coffey KR, Orlovskaya N, Sohn YH, Yang Y.

ACS Sens. 2017 May 26;2(5):621-625. doi: 10.1021/acssensors.7b00251. Epub 2017 May 17.


Levodopa dose maintenance or reduction in patients with Parkinson's disease transitioning to levodopa/carbidopa/entacapone.

Park J, Kim Y, Youn J, Lee PH, Sohn YH, Koh SB, Lee JY, Baik JS, Cho JW.

Neurol India. 2017 Jul-Aug;65(4):746-751. doi: 10.4103/neuroindia.NI_597_16.

Supplemental Content

Loading ...
Support Center